ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Elizabeth Holmes has more time cut off her sentence

Theranos founder Elizabeth Holmes has seen a few more months shaved off her prison sentence after originally being ordered to serve more than 11 years for fraud.

Theranos founder and convicted felon Elizabeth Holmes has had more time cut from her prison sentence, after her original release date was slashed by nearly two years last summer.

Holmes, 40, was originally ordered to serve more than 11 years behind bars after she was found guilty in January 2022 of four counts of fraud and conspiracy for deceiving investors in her now-defunct blood-testing company.

The former tech executive is serving her time at Federal Prison Camp Bryan, a women-only low-level security facility located in Bryan, Texas.

In July 2023, the Bureau of Prisons' (BOP) website showed her release date had been moved up to Dec. 29, 2032, just over 9.5 years after she checked into the prison on May 30 of that year.

ELIZABETH HOLMES TRIAL: WHAT JURY GOT RIGHT AND WRONG

Now, the BOP's records show four more months have been shaved off her time, with an updated release date of Aug. 16, 2032.

"For privacy, safety, and security reasons, our office does not comment on the conditions of confinement for any inmate, including release planning or release plans. However, we can provide the following general information," the Federal Bureau of Prisons told Fox Business.

The Bureau said inmates are eligible to earn good conduct time that can impact the projected release date. Certain inmates are also given the opportunity to participate and complete recidivism programs as well as drug abuse programs which help inmates release early.

SAM BANKMAN-FRIED APPEALS CONVICTION AND SENTENCING

Holmes quickly rose to stardom in Silicon Valley after she dropped out of Stanford University to launch Theranos at the age of 19. She amassed hundreds of millions of dollars, boasting to investors that her company could successfully diagnose many diseases with drops of blood. 

The empire she built came crashing down in 2015, however, after The Wall Street Journal reported her company was not using innovation, but traditional machines for its testing. The outlet also reported flaws in the diagnostics, further stifling her company’s claims.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

Holmes was indicted in 2018 alongside Theranos chief operating officer and former boyfriend Ramesh "Sunny" Balwani, who was found guilty of 12 counts of fraud. 

Judge Edward Davila of the United States District Court for the Northern District of California sentenced both Holmes and Balwani, ordering them to pay some $452 million in restitution to the victims of their crimes.

FOX Business' Lawrence Richard contributed to this report.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.